Ketamine clinics are springing up across the United States. Low, intravenous doses have been found to boost mood and curb suicidal thoughts. But, the U.S. Food and Drug Administration hasn’t approved it as a treatment for depression.
Monitoring of Schizophrenia medicine lands Canadian organization a Davies Award
The Center for Addiction and Mental Health (CAMH) in Canada earned a HIMSS Davies Award of Excellence.
Top healthcare executives can use IT to stem the opioid crisis
There were more than 40,000 opioid overdose deaths in 2017 and more than 2 million addicted in America.
Dramatic increase in use of vaping devices among America’s teens
There is a dramatic increase in the use of vaping devices among America’s teens in just a single year.
Kaiser Permanente mental health clinicians end 5-day strike
Behavioral health engagement solutions are instrumental in treating mental illness.